Can we track lymphoma in real time? new study aims to find out
NCT ID NCT07514715
First seen Apr 10, 2026 · Last updated Jun 22, 2026 · Updated 11 times
Summary
This study tests whether doctors can monitor minimal residual disease (tiny amounts of cancer left after treatment) in aggressive B-cell lymphoma patients using blood tests and PET scans in real time. About 129 participants will provide blood samples before, during, and after treatment, and have their PET scans reviewed centrally. The goal is to see if results can be delivered quickly enough to guide treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGGRESSIVE B-CELL LYMPHOMAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CENTRE HENRI BECQUEREL - Service Hématologie
Rouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CENTRE LEON BERARD - Service Hématologie
Lyon, 69373, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH D'AVIGNON - HOPITAL HENRI DUFFAUT - Service d'Onco-Hématologie
Avignon, 84000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CH DE VERSAILLES - HOPITAL ANDRE MIGNOT - Service Hématologie Adolescents et Jeunes Adultes
Le Chesnay, 78157, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHD DE VENDEE - Service Hématologie
La Roche-sur-Yon, 85925, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHRU NANCY - HÔPITAL BRABOIS - Service Hématologie
Vandœuvre-lès-Nancy, 54511, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU D'AMIENS - HOPITAL SUD - Service Hématologie Clinique et Thérapie Cellulaire
Amiens, 80054, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU D'ANGERS - Service des Maladies du Sang
Angers, 49033, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE BORDEAUX - HOPITAL HAUT-LEVEQUE - CENTRE FRANCOIS MAGENDIE - Service d'Hématologie et Thérapie Cellulaire
Pessac, 33604, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE GRENOBLE - Service Hématologie
La Tronche, 38700, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE LILLE - HOPITAL CLAUDE HURIEZ - Service des Maladies du Sang
Lille, 59037, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE MONTPELLIER - Département d'Hématologie Clinique
Montpellier, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE NANTES - Service Hématologie
Nantes, 44093, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE POITIERS - HOPITAL DE LA MILETRIE - Service d'Oncologie Hématologique et Thérapie Cellulaire
Poitiers, 86021, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DE REIMS - HOPITAL ROBERT DEBRE - Service Hématologie
Reims, 51092, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU DIJON BOURGOGNE - Service Hématologie Clinique
Dijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU ESTAING - Service Thérapie Cellulaire et Hématologie Clinique
Clermont-Ferrand, 63003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU JEAN MINJOZ - Service Hématologie
Besançon, 25030, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU LYON-SUD - Hématologie Clinique
Pierre-Bénite, 69495, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU ORLEANS - Service Oncologie Médicale
Orléans, 45067, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU PONTCHAILLOU - Hématologie Clinique
Rennes, 35033, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
GUSTAVE ROUSSY CANCER CAMPUS GRAND PARIS - Département Médecine Oncologique
Villejuif, 94085, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL COCHIN - Hématologie clinique
Paris, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL DE LA PITIE SALPETRIERE - Service Hématologie Clinique
Paris, 75651, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL HENRI MONDOR - Unité Hémopathies Lymphoïdes
Créteil, 94010, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL NECKER - Service Hématologie Adultes
Paris, 75743, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL SAINT VINCENT-DE-PAUL - Service Hématologie Clinique
Lille, 59020, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HOPITAL SAINT-LOUIS - Service Hématologie Adolescents et Jeunes Adultes
Paris, 75475, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INSTITUT CURIE - SITE SAINT-CLOUD - Service Hématologie
Saint-Cloud, 92210, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IUCT ONCOPOLE - Service Hématologie
Toulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could enable doctors to track cancer more accurately during treatment, potentially leading to better-tailored therapies.
What could go wrong
This is an early feasibility study, not testing a new treatment. It may show that the monitoring approach is not practical or reliable in real time.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.